Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk Factors and Interventions for PCOS with Depression and Anxiety
NCT04984070Unknown
- Sponsor
- Fudan University
- Start
- Jan 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of liquid metformin (Aspargo Labs), ethinyl estradiol + cyproterone and ethinyl estradiol + drospirenone in polycystic ovary syndrome (PCOS), sponsored by Fudan University. Primary endpoints: Depression at 1 year, Anxiety at 1 year and 1 more. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)ethinyl estradiol + cyproteroneethinyl estradiol + drospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04984070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04984070.